Source: Manufacturing Chemist

Followers on Owler

Est. Annual Revenue

$5.0-25M

Est. Employees

25-100

Managing Director & CEO

Carsten Rudolph

CEO Approval Rating

85/100

Ethris is a Germany-based biotechnology company that develops and commercializes RNA therapeutics for the treatment of respiratory viral infections.

Ethris received $5M in Unattributed Funding